Chardan Upgrades Regeneron Amid Relative Underperformance To Amgen Shares

By: via Benzinga
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) shares have been trending south in 2016, and are down 30 percent since January ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.